Sundar Jagannath, MD
Dr. Jagannath is the Director of the Multiple Myeloma Center of Excellence at Tisch Cancer Institute, Mount Sinai Hospital, New York, NY. He is also Professor of Medicine and Mount Sinai Endowed Chair for Multiple Myeloma at Mount Sinai School of Medicine.
A board-certified specialist in internal medicine and medical oncology, Dr. Jagannath received his medical degree in 1974 at Maharaja Sayajirao University in Baroda, India, and continued his medical training with a fellowship in immunovirology at McMaster University Medical Center in Hamilton, Ontario, Canada. His residency was completed at the Bronx-Lebanon Hospital in New York City, and at Harper-Grace Hospital, Wayne State University, in Detroit, Michigan. Dr. Jagannath also completed a medical oncology fellowship at University of Texas System Cancer Center – MD Anderson Hospital and Tumor Institute in Houston, Texas. He is a former professor of pathology and medicine at the University of Arkansas, where he served as chief of bone marrow transplantation from 1989 to 1997. Dr. Jagannath was appointed chief of bone marrow and blood stem cell transplantation and chief of the multiple myeloma program at St Vincent’s Comprehensive Cancer Center in New York City from 1998 to 2010.
A renowned expert in Multiple Myeloma and Bone Marrow Transplantation, Dr. Jagannath has published extensively on these topics and is often an invited presenter at professional organizations’ annual meetings. He is editor-in-chief of Clinical Lymphoma, Myeloma & Leukemia and a peer reviewer for many other journals. Dr. Jagannath is a board member for the Society of Hematologic Oncology and International Myeloma Society. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology. In 2003, Dr Jagannath received the Humanitarian Award from the Multiple Myeloma Research Foundation, and in 2006, 2009, and 2010 he was the recipient of the Foundation’s Laugh for Life Award. In 2017, Dr. Jagannath received the Innovator Award from the Multiple Myeloma Research Consortium (MMRC). Most recently, Dr. Jagannath received the 2018 Fellow of the American Society of Clinical Oncology Award (FASCO).
